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Background 
The application of MR methods to follow the biological conversion of hyperpolarized 13C -labelled metabolites provides a non-invasive means to 
study metabolism in real time.   The high metabolic activity of the heart makes this technique particularly suited to detect the changes in cardiac 
metabolism known to result from heart failure or ischemic injury [1,2].  Energy metabolism in ischemic rat hearts has been interrogated with 
hyperpolarized 13C-labelled pyruvate ex vivo [3,4], and its hyperpolarized metabolites have been imaged in the ischemic pig heart in vivo [5]. In both, 
cases an increase in the conversion to labelled lactate vs. bicarbonate is observed, reflecting the expected decrease in pyruvate oxidation.  As a 
widely-used laboratory animal, the rat provides an attractive platform for cardiac metabolic studies, benefiting from well-established disease models 
and an extensive body of work on its physiology and metabolism.   
 
Methods 
Animal Model.  Male Wistar rats (n=8, 262 ±14g) were anesthetized with isoflurane and intubated.  Catheters were installed in the femoral arteries 
for blood sampling and invasive blood pressure measurement and in a femoral vein for infusion. Myocardial ischemia was effected via occlusion 
with a snare installed by passing a suture underneath the left coronary artery.  The two ends of the suture were then threaded through a small piece of 
tubing, to form the snare around the left coronary artery.  The reversible occlusion was created by tightening the snare and holding it in place with a 
clip for 15 minutes (no occlusion in control experiments) and hyperpolarized sodium [1-13C]pyruvate was infused as soon as possible afterward.  At 
the end of the experiment, the heart was stained with Evans blue to assess the extent of the ischemic area.    
Polarization. 12 x 10μl glassy beads of a frozen 2.7M sodium [1-13C]pyruvate and 50mM TEMPOL in HOD and glycerol (18% v/v) were polarized 
with microwave irradiation (197.25 GHz, 55mW) for ~2hr at 1.0K in a custom-built 7T polarizer.  The sample was rapidly dissolved in 6mL of 
preheated D2O and transferred automatically to a phase separator / infusion pump in the magnet bore [6], where its polarization was ~20%, and 
1.7mL was infused IV by remote control.   
MR acquisition.  Scanning was formed in a 9.4T 31cm horizontal bore magnet with a VNMRS console (Varian).  A surface coil with a single loop 
for 1H and two overlapping loops in quadrature for 13C was positioned over the heart.  Breathing motion and blood pressure signals were used for 
respiratory and cardiac gating.  Coil placement was confirmed with 1H anatomical images.  Following the hyperpolarized 13C infusion, dynamic 
series of 40 single pulse 13C spectra were acquired (gated, TR≈3s) using a 30º BIR4 pulse centered at ~175 ppm.    
Data analysis. Spectral peaks of metabolites were quantified by fitting using Bayes (Washington 
University).  Areas under curve (AUC) for metabolite hyperpolarized signal time courses were 
calculated using the spectral signal amplitude and the variable interval between the gated 
acquisitions.  Ratios of 13C-bicarbonate-to-[1-13C]lactate AUCs acquired before and after the 
ischemic occlusion were compared.  Student’s t-test was used to assess statistical significance. 
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Figure 1.  Timeline of hyperpolarized myocardial ischemia experiment 
 
Results and Discussion 
The conversion of [1-13C]pyruvate to its metabolites [1-13C]lactate, [1-13C]alanine and 13C -
bicarbonate was detected before and after myocardial ischemia.  Quantitation of the peak areas 
revealed a significant reduction in the bicarbonate-to-lactate ratio, 1.49 ± 0.10 fold lower, 
compared to 0.96 ± 0.23 in control experiments (p < 0.01), consistent with a shift away from 
oxidative metabolism and to anaerobic, glycolytic metabolism. While the bicarbonate-to-lactate 
ratio varied between animals, its variation between consecutive infusions of hyperpolarized [1-
13C]pyruvate was smaller and more consistent. The mean delay between the removal of the 
occlusion and the start of the infusion was 105 s (range: 80-120 s); greater differences may be 
observed in earlier reperfusion. 
Conclusion 
This study demonstrates the feasibility of using hyperpolarized 13C MRS to detect metabolic 
changes in rat myocardial metabolism in vivo after a brief ischemic episode, which provides the 
opportunity to investigate changes in energy metabolism with other probes.  Additionally, the 
functional effects of other interventions, such as metabolism-modulating drugs, can be investigated. 
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Figure 2.  Change in the hyperpolarized 
bicarbonate-to-lactate ratio before and after 15 
min occlusion of the left coronary artery.    
BL: baseline, RP: reperfusion   
 
Figure 3.  Evans blue-stained heart slices 
showing extent of unstained ischemic region 
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